CVS HEALTH CORP (CVS) 73.26 +0.89 (+1.23%)
73.26 +0.89 (+1.23%)
US1266501006 - Common Stock - After market: 73.5 +0.24 (+0.33%)
Buy % Consensus
Analysts have set a mean price target of 115.79. This target is 58.06% above the current price.
CVS was analyzed by 31 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CVS.
In the previous month the buy percentage consensus was at a similar level.
CVS was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-09 | RBC Capital | Reiterate | Outperform |
| 2023-02-09 | Barclays | Maintains | Overweight |
| 2023-02-09 | Raymond James | Maintains | Outperform |
| 2023-02-09 | Jefferies | Maintains | Buy |
| 2023-01-13 | Morgan Stanley | Maintains | Overweight |
| 2023-01-03 | Wells Fargo | Maintains | Equal-Weight |
| 2023-01-03 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-11-21 | Credit Suisse | Maintains | Outperform |
| 2022-11-08 | Wells Fargo | Maintains | Equal-Weight |
| 2022-11-07 | RBC Capital | Maintains | Outperform |
| 2022-11-07 | Raymond James | Maintains | Outperform |
| 2022-11-03 | JP Morgan | Maintains | Overweight |
| 2022-11-03 | Goldman Sachs | Maintains | Buy |
| 2022-10-20 | B of A Securities | Maintains | Buy |
| 2022-10-11 | Morgan Stanley | Maintains | Overweight |
| 2022-09-07 | Evercore ISI Group | Maintains | Outperform |
| 2022-08-15 | Mizuho | Maintains | Buy |
| 2022-08-08 | Credit Suisse | Maintains | Outperform |
| 2022-08-04 | UBS | Maintains | Buy |
| 2022-06-17 | Loop Capital | Initiate | Buy |
| 2022-05-27 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2022-05-05 | Deutsche Bank | Maintains | Hold |
| 2022-05-05 | Morgan Stanley | Maintains | Overweight |
| 2022-02-14 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2021-12-23 | Tigress Financial | Maintains | Buy |
| 2021-12-20 | Mizuho | Maintains | Buy |
| 2021-12-14 | Goldman Sachs | Initiate | Buy |
| 2021-12-13 | Wells Fargo | Maintains | Equal-Weight |
| 2021-12-13 | Morgan Stanley | Maintains | Overweight |
| 2021-12-10 | Mizuho | Maintains | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA